Rick Jantz

    • X4 Pharmaceuticals in its Exclusive License Agreement with Abbisko Therapeutics 

    • GENFIT SA in its Licensing and Collaboration Agreement with Terns Pharmaceuticals 

    • Vir Biotechnology - $143 Million IPO 

    • Arlo to Partner with Verisure 

    • Reata Pharmaceuticals – $505 Million Follow-On Offering 

    • Synthorx to Sell to Sanofi for $2.5 Billion 

    • Vivid Cortex Sells to SolarWinds  

    • DocuSign to Acquire AI Technology Provider Seal Software 

    • Genesis MedTech Acquires Drug Device Asset From TriReme Medical